ArticleBMC ophthalmology2026
The association between magnesium and diabetic retinopathy: a cross-sectional study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the clinical significance of serum magnesium in non-diabetic mellitus (non-DM), diabetes mellitus (DM) and diabetic retinopathy (DR). Moreover, to assess magnesium concentration in DR mice models.
methodsBaseline data from 150 patients per group (non-DM, DM, DR) comprised demographics, cardiovascular-metabolic profiles, electrolytes, and systemic immune-inflammatory were collected and analyzed. Logistic regression analysis was used to screen influencing factors for DR. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic utility of hemoglobin A1c (HbA1c) and magnesium. Magnesium concentration in both serum and retinal tissues of DR mice were quantified via the methylthymol blue assay.
resultsCompared with the non-DM group, the DM group had lower age and blood pressure levels (P < 0.05), while heart rate, HbA1c and serum phosphorus levels were significantly higher (P < 0.05). Serum sodium and magnesium levels decreased gradually across the non-DM, DM and DR groups (P < 0.05), whereas heart rate and HbA1c levels increased progressively in the three groups (P < 0.05). Compared with DM, those with DR had longer diabetic duration. Ordinal multinomial logistic regression among non-DM, DM and DR groups indicated that HbA1c was positively associated with DR risk, whereas magnesium was negatively correlated with DR. Binary logistic regression between DM and DR groups showed that diabetes duration, SBP and HbA1c were positively related to elevated DR risk, and magnesium was negatively associated with the occurrence of DR. The ROC curve analysis revealed that a combined diagnostic of HbA1c and serum magnesium, with cut-off value of 0.500, achieved a sensitivity of 78.7% and a specificity of 90.0% for DM. The combined diagnosis of HbA1c and magnesium, with cut-off value of 0.441, approached a sensitivity of 75.3% and a specificity of 66.0% for DR. DR mice exhibited lower magnesium levels in both serum and retinal tissues compared with the control mice (P < 0.05).
conclusionPatients with DR had longer disease duration, elevated HbA1c levels and decreased serum magnesium concentrations. Combined detection of serum magnesium and HbA1c can significantly improve the diagnostic performance of DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.